|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation expense | |||||
| Depreciation and amortization | |||||
| Right-of-use asset - operating lease | |||||
| Stock-based compensation expense | |||||
| Loss on disposal of property and equipment | |||||
| Non-cash royalty revenue related to sale of future royalties | |||||
| Gain on early termination of lease | |||||
| Non-cash interest expense on liability related to sale of future royalties | |||||
| Non-cash interest expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Other receivables | |||||
| Prepaid expenses | |||||
| Deposits | |||||
| Other current assets | |||||
| Other non-current assets | |||||
| Operating lease liability | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Interest payable | |||||
| Deferred grant funding | |||||
| Deferred revenue | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the exercise of stock options | |||||
| Proceeds from the exercise of common stock warrants | |||||
| Proceeds from the sale of future royalties, net | |||||
| Net proceeds from issuance of common stock | |||||
| Payments of deferred offering costs | |||||
| Repayment of liability on sale of future royalties | |||||
| Issuance of note payable | |||||
| Payments on note payable | |||||
| Principal payments on finance lease | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Remeasurement of operating lease right-of-use assets and lease liabilities due to lease modification | |||||
| Finance right-of-use assets obtained in exchange for new finance lease liabilities | |||||
| Remeasurement of finance lease right-of-use assets and lease liabilities due to lease modification | |||||
| Prepaid rent reclassified to finance lease right-of-use asset | |||||
| Deferred issuance costs applied from prepayments made in the prior year | |||||
| Issuance cost on equity paid in common stock | |||||
| Issuance cost recorded under additional-paid-in-capital | |||||
| Additions to property and equipment and reduction of deposits | |||||
| Reconciliation of cash, cash equivalents and restricted cash to amounts reported in the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other non-current assets | |||||
Loading...